Based on the results of the compassionate use program,
enrollment commenced in a randomized, controlled,
investigator-initiated clinical trial in up to 150 patients
of rhC1INH for the treatment with confirmed COVID-19
infections hospitalized with related severe pneumonia
at the University Hospital Basel in Basel, Switzerland.
The study was extended to several other centers in
Switzerland, Brazil and Mexico. In addition, enrollment has
commenced in a second investigator-initiated randomized,
open label, parallel group, controlled, pilot clinical trial in
up to 120 patients hospitalized with confirmed COVID-19
treated with RUCONEST® for the prevention of severe
SARS-CoV-2 infections at the Valley Hospital in Ridgewood,
Alleen al het feit dat Pharming dit onderzoek steeds opnemen in hun verslag geeft me een goed gevoel over de uiteindelijke resultaten, dus gewoon geduld hebben.
Volgens experts die gezegd hebben dat Covid-19 de wereld nooit meer gaat verlaten kan hopelijk Ruconest wel bij gaan dragen als symptoom bestrijding hiervan.